[24] [25] Weight management medications (including GLP-1 receptor agonists and orlistat) should generally be deferred until after weaning, unless exceptional circumstances warrant earlier intervention with careful risk-benefit assessment by specialists
"Every medication carries a risk, and they don't affect everyone equally," said Jessica Bartfield, a clinical associate professor at Wake Forest University's Bariatric and Weight Management Center
Everyones skin is different, and factors like diet, sun exposure, and genetics influence how quickly you notice changes
They usually focus on: Arguing that compounded GLP-1s are essentially copies of brand-name drugs Restricting use of certain versions, like salt forms Clarifying that adding something minor like B12 does not make it legally different Ending compounding once a drug is no longer considered in shortage Intent: Rein in or eliminate compounded versions of specific blockbuster drugs
(2025 update) As of April 2025, there is no FDA-approved generic version of semaglutide (the active ingredient in Ozempic and Wegovy) available in the United States
This powerful antioxidant has taken the beauty and skincare industry by storm, promising skin brightening, anti-aging and overall radiant skin
.png)
